130 related articles for article (PubMed ID: 38577347)
1. A Multidisciplinary approach to metastatic giant basal cell carcinoma-A case report.
Lehto LET; Ristola MT; Mäntylä V; Pajula S
JPRAS Open; 2024 Jun; 40():190-193. PubMed ID: 38577347
[TBL] [Abstract][Full Text] [Related]
2. [Successful therapy of metastatic basal cell carcinoma with vismodegib].
Zutt M; Mazur F; Bergmann M; Lemke AJ; Kaune KM
Hautarzt; 2014 Nov; 65(11):974-7. PubMed ID: 25217085
[TBL] [Abstract][Full Text] [Related]
3. Treatment of basal cell carcinoma with vismodegib: future or present?
Velleman J; Kaarela O; Vranckx JJ
Acta Chir Belg; 2021 Jun; 121(3):198-203. PubMed ID: 31437079
[TBL] [Abstract][Full Text] [Related]
4. Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib.
Su MG; Potts LB; Tsai JH
Am J Ophthalmol Case Rep; 2020 Sep; 19():100755. PubMed ID: 32490287
[TBL] [Abstract][Full Text] [Related]
5. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.
Bertrand N; Guerreschi P; Basset-Seguin N; Saiag P; Dupuy A; Dalac-Rat S; Dziwniel V; Depoortère C; Duhamel A; Mortier L
EClinicalMedicine; 2021 May; 35():100844. PubMed ID: 33997740
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib.
Martins PC; Filipe RV; Barbosa R; Julião I; Azevedo R; Ribeiro M; de Sousa A
Autops Case Rep; 2019; 9(4):e2019116. PubMed ID: 31641658
[TBL] [Abstract][Full Text] [Related]
7. Invasive Basal Cell Carcinoma of the Skin Treated Successfully with Vismodegib: A Case Report.
Awad R; Andrade JCB; Mousa H; Mahmoud F
Perm J; 2018; 22():17-181. PubMed ID: 30005721
[TBL] [Abstract][Full Text] [Related]
8. Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib.
Orduz Robledo M; Lebas E; Reginster MA; Baghaie M; Groves S; Nikkels AF
Rare Tumors; 2018; 10():2036361318772938. PubMed ID: 29760872
[TBL] [Abstract][Full Text] [Related]
9. Vismodegib (ERIVEDGE°) In basal cell carcinoma: too many unknowns.
Prescrire Int; 2015 Jan; 24(156):11-4. PubMed ID: 25729822
[TBL] [Abstract][Full Text] [Related]
10. Metatypical basal cell carcinoma: from the primary tumour to a generalized metastatic process - description of diagnostics and combination therapy of an extremely rare skin cancer.
Madej-Czerwonka B; Korga-Plewko A
Ann Agric Environ Med; 2022 Mar; 29(1):152-156. PubMed ID: 35352920
[TBL] [Abstract][Full Text] [Related]
11. Giant Basal Cell Carcinoma of the Axilla: 8-year Follow-up of a Case Treated with Excision, Vismodegib, and Radiotherapy.
Kuo SC; Lee YC
J Drugs Dermatol; 2022 May; 21(5):531-533. PubMed ID: 35533027
[TBL] [Abstract][Full Text] [Related]
12. Complete remission of advanced, locally invasive basal cell carcinoma with vismodegib.
Glen P; Farrugia D; Farrier J
Int J Oral Maxillofac Surg; 2020 Sep; 49(9):1149-1152. PubMed ID: 32204965
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Tang JY; Ally MS; Chanana AM; Mackay-Wiggan JM; Aszterbaum M; Lindgren JA; Ulerio G; Rezaee MR; Gildengorin G; Marji J; Clark C; Bickers DR; Epstein EH
Lancet Oncol; 2016 Dec; 17(12):1720-1731. PubMed ID: 27838224
[TBL] [Abstract][Full Text] [Related]
14. Metastatic basal cell carcinoma with atypical pattern of spread.
Gellatly M; Cruzval-O'Reilly E; Mervak JE; Mervak BM
Radiol Case Rep; 2020 Dec; 15(12):2641-2644. PubMed ID: 33088379
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant vismodegib in the management of locally advanced periocular basal cell carcinoma.
Curragh DS; Huilgol SC; Selva D
Eye (Lond); 2021 Oct; 35(10):2740-2745. PubMed ID: 33235336
[TBL] [Abstract][Full Text] [Related]
16. Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449).
Meani RE; Lim SW; Chang AL; Kelly JW
Australas J Dermatol; 2014 Aug; 55(3):218-21. PubMed ID: 25117162
[TBL] [Abstract][Full Text] [Related]
17. Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face.
Block AM; Alite F; Diaz AZ; Borrowdale RW; Clark JI; Choi M
Case Rep Oncol Med; 2015; 2015():827608. PubMed ID: 26504605
[TBL] [Abstract][Full Text] [Related]
18. Extensive bony metastases from facial metatypical basal cell carcinoma: a case report.
Pabst A; Klinghuber M; Müller G; Vandersee S; Werkmeister R
Br J Oral Maxillofac Surg; 2019 Jan; 57(1):82-84. PubMed ID: 30598320
[TBL] [Abstract][Full Text] [Related]
19. Super giant basal cell carcinoma in an autistic patient: A case report.
Hudson E; Abu Hilal M
SAGE Open Med Case Rep; 2020; 8():2050313X20939481. PubMed ID: 32733678
[TBL] [Abstract][Full Text] [Related]
20. Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma.
Alcalay J; Tauber G; Fenig E; Hodak E
J Drugs Dermatol; 2015 Mar; 14(3):219-23. PubMed ID: 25738842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
